Snyder Capital Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $8.39M | Sell |
|
|||||
|
2021
Q4 | $29.7M | Sell |
|
|||||
|
2021
Q3 | $42.2M | Buy |
|
|||||
|
2021
Q2 | $50.4M | Buy |
|
|||||
|
2021
Q1 | $71.5M | Buy |
|
|||||
|
2020
Q4 | $64.8M | Buy |
|
|||||
|
2020
Q3 | $68.7M | Sell |
|
|||||
|
2020
Q2 | $70.4M | Sell |
|
|||||
|
2020
Q1 | $59.7M | Sell |
|
|||||
|
2019
Q4 | $62.2M | Sell |
|
|||||
|
2019
Q3 | $61.8M | Buy |
|
|||||
|
2019
Q2 | $47.7M | Sell |
|
|||||
|
2019
Q1 | $51.6M | Buy |
|
|||||
|
2018
Q4 | $57.3M | Sell |
|
|||||
|
2018
Q3 | $73.3M | Sell |
|
|||||
|
2018
Q2 | $57.2M | Sell |
|
|||||
|
2018
Q1 | $64.5M | Sell |
|
|||||
|
2017
Q4 | $57.7M | Buy |
|
|||||
|
2017
Q3 | $44.4M | Buy |
|
|||||
|
2017
Q2 | $37.1M | Sell |
|
|||||
|
2017
Q1 | $32.9M | Buy |
|
|||||
|
2016
Q4 | $31.6M | Buy |
|
|||||
|
2016
Q3 | $24.4M | Buy |
|
|||||
|
2016
Q2 | $15M | Buy |
|
|||||
|
2016
Q1 | $11.1M | Sell |
|
|||||
|
2015
Q4 | $13.2M | Buy |
|